Bank of America Securities Reaffirms Their Hold Rating on Zoetis (ZTS)

In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Hold rating on Zoetis, with a price target of $140.00. The company’s shares closed yesterday at $128.96.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Ryskin is a 3-star analyst with an average return of 2.3% and a 51.48% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as Illumina, Zoetis, and Elanco Animal Health.

Currently, the analyst consensus on Zoetis is a Moderate Buy with an average price target of $147.44, a 14.33% upside from current levels. In a report released on February 20, Stifel Nicolaus also maintained a Hold rating on the stock with a $130.00 price target.

Based on Zoetis’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $2.39 billion and a net profit of $603 million. In comparison, last year the company earned a revenue of $2.32 billion and had a net profit of $581 million

Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ZTS in relation to earlier this year. Last month, Kristin Peck, the CEO of ZTS sold 20,000.00 shares for a total of $2,540,864.00.